PMID- 34999279 OWN - NLM STAT- MEDLINE DCOM- 20220321 LR - 20220321 IS - 1618-0631 (Electronic) IS - 0344-0338 (Linking) VI - 230 DP - 2022 Feb TI - The clinical significance of transcription factor WD repeat and HMG-box DNA binding protein 1 in laryngeal squamous cell carcinoma and its potential molecular mechanism. PG - 153751 LID - S0344-0338(21)00412-X [pii] LID - 10.1016/j.prp.2021.153751 [doi] AB - BACKGROUND: Currently, high expression of WD repeat and HMG-box DNA binding protein 1 (WDHD1) has been found in a variety of tumors; but there is no research has been conducted concerning the expression of WDHD1 in laryngeal squamous cell carcinoma (LSCC). Our purpose is to investigate the expression and the latent mechanism of WDHD1 in LSCC. METHODS: Firstly, 9 data sets from the Gene Expression Omnibus (GEO), The Cancer Genome Atlas (TCGA), and ArrayExpress were statistically analyzed to explore the expression of WDHD1 in LSCC; immunohistochemistry was performed in 79 LSCC tissues and 44 non-cancer tissues to further verify the result. In addition, the target gene of WDHD1 was predicted and immunohistochemistry was used to detect the expression of the target gene. The potential mechanism of WDHD1 in LSCC was investigated by Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses and protein-protein interaction network (PPI). RESULTS: The WDHD1 mRNA was expressed at higher levels in the LSCC tissue than in the normal tissue (SMD=1.90, 95% CI=1.50-2.30); and the results of immunohistochemistry were consistent with the conclusion. Using chip-seq analysis, we found that S-phase kinase-associated protein 2 (Skp2) had a significant binding peak with WDHD1, and the expression of these two genes was significantly positively correlated. Immunohistochemistry showed that Skp2 was also highly expressed in LSCC. In addition, GO and KEGG analysis revealed the WDHD1 positively correlated genes was closely related to cell cycle, and PPI analysis identified 10 hub genes: COL7A1, COL4A2, COL4A1, COL4A6, COL11A1, COL5A2, COL1A1, COL13A1, COL8A1 and COL10A1, which may be critical to the progression of LSCC. CONCLUSIONS: WDHD1 was overexpressed in LSCC tissues. Meanwhile, WDHD1 and its target gene Skp2 for transcriptional regulation may play a role in the progression of LSCC by regulating the cell cycle. CI - Copyright (c) 2022 The Authors. Published by Elsevier GmbH.. All rights reserved. FAU - Wu, Ji-Yun AU - Wu JY AD - Department of Radiotherapy, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Rd, Nanning, Guangxi Zhuang Autonomous Region 530021, PR China. FAU - Lan, Xiao-Lu AU - Lan XL AD - Department of Traditional Chinese Medicine, YiZhou District Hospital of Traditional Chinese Medicine, Jiulong Road, YiZhou, Hechi, Guangxi Zhuang Autonomous Region 546399, PR China. FAU - Yan, Dong-Mei AU - Yan DM AD - Department of Radiotherapy, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Rd, Nanning, Guangxi Zhuang Autonomous Region 530021, PR China. FAU - Fang, Ye-Ying AU - Fang YY AD - Department of Radiotherapy, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Rd, Nanning, Guangxi Zhuang Autonomous Region 530021, PR China. FAU - Peng, Yun-Xi AU - Peng YX AD - Department of Radiotherapy, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Rd, Nanning, Guangxi Zhuang Autonomous Region 530021, PR China. FAU - Liang, Fei-Fei AU - Liang FF AD - Department of Radiotherapy, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Rd, Nanning, Guangxi Zhuang Autonomous Region 530021, PR China. FAU - Jiang, Li AU - Jiang L AD - Department of Radiotherapy, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Rd, Nanning, Guangxi Zhuang Autonomous Region 530021, PR China. FAU - Huang, Su-Ning AU - Huang SN AD - Department of Radiotherapy, Guangxi Medical University Cancer Hospital, No.71 Hedi Rd, Nanning, Guangxi Zhuang Autonomous Region 530021, PR China. FAU - Mo, Miao AU - Mo M AD - Department of Radiotherapy, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Rd, Nanning, Guangxi Zhuang Autonomous Region 530021, PR China. FAU - Lin, Cai-Xing AU - Lin CX AD - Department of Radiotherapy, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Rd, Nanning, Guangxi Zhuang Autonomous Region 530021, PR China. FAU - Niu, Yi-Tong AU - Niu YT AD - Department of Radiotherapy, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Rd, Nanning, Guangxi Zhuang Autonomous Region 530021, PR China. FAU - Wu, Xiao-Wei AU - Wu XW AD - Department of Radiotherapy, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Rd, Nanning, Guangxi Zhuang Autonomous Region 530021, PR China. FAU - Wei, Zhu-Xin AU - Wei ZX AD - Department of Radiotherapy, First Affiliated Hospital of Guangxi Medical University, 6 Shuangyong Rd, Nanning, Guangxi Zhuang Autonomous Region 530021, PR China. Electronic address: weizhuxin@stu.gxmu.edu.cn. LA - eng PT - Journal Article DEP - 20211223 PL - Germany TA - Pathol Res Pract JT - Pathology, research and practice JID - 7806109 RN - 0 (DNA-Binding Proteins) RN - 0 (S-Phase Kinase-Associated Proteins) RN - 0 (SKP2 protein, human) RN - 0 (WDHD1 protein, human) RN - 9007-34-5 (Collagen) SB - IM MH - Cell Cycle MH - Cell Proliferation MH - Collagen/genetics/metabolism MH - DNA-Binding Proteins/genetics/*metabolism MH - Databases, Genetic MH - Female MH - Gene Expression Regulation, Neoplastic MH - Gene Regulatory Networks MH - Humans MH - Laryngeal Neoplasms/genetics/*metabolism/pathology MH - Male MH - Middle Aged MH - Protein Interaction Maps MH - S-Phase Kinase-Associated Proteins/genetics/metabolism MH - Signal Transduction MH - Squamous Cell Carcinoma of Head and Neck/genetics/*metabolism/pathology OTO - NOTNLM OT - High throughput data OT - Immunohistochemistry OT - Laryngeal squamous cell carcinoma OT - Transcription factor OT - WD repeat and HMG-box DNA binding protein 1 EDAT- 2022/01/10 06:00 MHDA- 2022/03/22 06:00 CRDT- 2022/01/09 20:50 PHST- 2021/07/18 00:00 [received] PHST- 2021/12/21 00:00 [revised] PHST- 2021/12/21 00:00 [accepted] PHST- 2022/01/10 06:00 [pubmed] PHST- 2022/03/22 06:00 [medline] PHST- 2022/01/09 20:50 [entrez] AID - S0344-0338(21)00412-X [pii] AID - 10.1016/j.prp.2021.153751 [doi] PST - ppublish SO - Pathol Res Pract. 2022 Feb;230:153751. doi: 10.1016/j.prp.2021.153751. Epub 2021 Dec 23.